Theophylline Therapy

References

• Herman G, Aynesworth M B, Martin J. Successful treatment of persistent dyspnea ‘status asth-maticus’. J Lab Clin Med 1937; 23: 135–145
   Google Scholar
• Pierson W E, Bierman C W, Stamm S J, et al. Double-blind trial of aminophylline in status asth-maticus. Pediatrics 1971; 48: 642–646
   PubMed Web of Science ®Google Scholar
• Jackson R H, McHenry J I, Moreland F B, et al. Clinical evaluation of elixophyllin with correlation of pulmonary function studies and theophylline serum levels in acute and chronic asthmatic patients. Dis Chest 1964; 45: 75–85
   PubMedGoogle Scholar
• Turner-Warwick M. Study of theophylline plasma levels after oral administration of new theophylline compounds. Br Med J 1957; 2: 67–79
   PubMed Web of Science ®Google Scholar
• Weinberger M M, Bronsky E A. Evaluation of oral bronchodilator therapy in asthmatic children. J Pediat 1974; 84: 421
   PubMed Web of Science ®Google Scholar
• Nassif E G, Weinberger J, Thompson R, et al. The value of maintenance theophylline in steroid-dependent asthma. N Engl J Med 1981; 304: 71
   PubMedGoogle Scholar
• Schack J A, Waxier S H. An ultraviolet spec-trophotometric method for the determination of theophylline and theobromine in blood and tissues. J Pharmacol Exp Ther 1949; 97: 283–291
   PubMed Web of Science ®Google Scholar
• Andersson K-E, Persson C G. Extrapulmonary effects of theophylline. Eur J Resp Dis 1980; 61(Suppl 109)17
   Google Scholar
• Rall T W. Central nervous system stimulants: The xanthines. The Pharmacological Basis of Therapeutics, 6th ed, A G Goodman, L S Goodman, A Gilman, 1980; 592–607
   Google Scholar
• Sigrist S, Thomas D, Howell S, et al. The effect of aminophylline on inspiratory muscle contractility. Am Rev Resp Dis 1982; 126: 46
   PubMedGoogle Scholar
• Aubler M, De Troyer A, Sampson M, et al. Aminophylline improves diaphragmatic contractility. N Engl J Med 1981; 305: 249
   PubMedGoogle Scholar
• Lakshminarayan S, Sahn S A, Weil J V. Effect of aminophylline on ventilatory responses in normal man. Am Rev Resp Dis 1978; 117: 33
   PubMed Web of Science ®Google Scholar
• Sanders J S, Berman T M, Bartlett M M, et al. Increased hypoxic ventilatory drive due to administration of aminophylline in normal men. Chest 1980; 73: 279
   Google Scholar
• Shannon O G, Gotay F, Stein I M, Rogers M C, Todres I D, Moylan F MB. Prevention of apnea and bradycardia in low birthweight infants. Pediatrics 1975; 55: 589
   PubMed Web of Science ®Google Scholar
• Isles A F, MacLeod S M, Levison H. Theophylline. New thoughts about an old drug. Chest 1982; 82(Supp)495
   Google Scholar
• Butcher R W, Sutherland E W. Adenosine 3′5′-phosphate in biological materials. J Biol Chem 1962; 237: 1244–1250
   PubMed Web of Science ®Google Scholar
• Sutherland E W, Robison G A, Butcher R W. Some aspects of the biological role of adenosine 3′5′-monophosphate (cyclic AMP). Circulation 1968; 38: 279–306
   Google Scholar
• Newman D J, Colella D F, Spainhour C B, et al. cAMP-phosphodiesterase inhibitors and tracheal smooth muscle relaxation. Biochem Pharmacol 1978; 27: 729–732
   PubMedGoogle Scholar
• Triner L, Vulliemoz Y, Veronsky M. Cyclic 3′5′-adenosine monophosphate and bronchial tone. Eur J Pharmacol 1977; 41: 37–46
   PubMedGoogle Scholar
• Dolson J B, Krzanowski J, Goldman A I, et al. Inhibition of human pulmonary phosphodiesterase activity by therapeutic levels of theophylline. Clin Exp Pharmacol Physiol 1978; 5: 535–539
   PubMedGoogle Scholar
• Kolbeck R C, Speir W A, Carrier G O, et al. Apparent irrelevance of cyclic nucleotides to the relaxation of tracheal smooth muscle induced by theophylline. Lung 1979; 156: 173
   PubMedGoogle Scholar
• Bergstrand H, Lundquist B, Schurmann A. Rat mast cell high affinity cyclic nucleotide phosphodiesterase: Separation and inhibitory effects of two antiallergic agents. Mol Pharmacol 1978; 14: 845
   Google Scholar
• Bergstrand H. Phosphodiesterase inhibition and theophylline. Eur J Resp Dis 1980; 61(Suppl 109)37
   Google Scholar
• Fredholm B. Theophylline actions on adenosine receptors. Eur J Resp Dis 1980; 61(Suppl 109)29–35
   Google Scholar
• Persson C GA, Erjefalt I, Karlsson X. Adenosine antagonism, a less desirable characteristic of xanthine asthma drugs?. Acta Pharmacol Toxicol 1981; 49: 317
   PubMedGoogle Scholar
• Lunell E, Svedmyr N, Andersson K-E, et al. Effects of enprofylline, a xanthine lacking adenosine receptor antagonism, in patients with chronic obstructive lung disease. Eur J Clin Pharmacol 1982; 22: 395
   PubMedGoogle Scholar
• Horrobin D F, Manku M S, Franks O J, et al. Meth-ylxanthine phosphodiesterase inhibitors behave as prostaglandin antagonists in a perfused rat mes-enteric artery preparation. Prostaglandins 1977; 13: 33–40
   PubMed Web of Science ®Google Scholar
• Plafsky K M, Ogilvie R I. Drug therapy. Dosage of theophylline in bronchial asthma. N Engl J Med 1974; 292: 1218
   Google Scholar
• Hendeles L, Weinberger M, Johnson G. Theophylline. Applied Pharmacokinetics, W E Evans, J J Schentag, W J Jusko. Applied Therapeutics, Inc, San Francisco 1980; 95–113
   Google Scholar
• Powell J R, Jackson J E. Counterpoint discussion: Theophylline. Applied Pharmacokinetics, W E Evans, J J Schentag, W J Jusko. Applied Therapeutics, Inc., San Francisco 1980; 139–160
   Google Scholar
• Mitenko P A, Ogilvie R I. Rational Intravenous doses of theophylline. N Engl J Med 1973; 289: 600
   PubMed Web of Science ®Google Scholar
• Svedmyr N, Simonsson B G. Drugs in the treatment of asthma. Pharmacol Ther B 1978; 3: 397
   PubMedGoogle Scholar
• Karlsson J A, Persson C GA. Influence of tracheal contraction on relaxant effects in vitro of theophylline and isoprenaline. Br J Pharmacol 1981; 74: 73
   PubMed Web of Science ®Google Scholar
• Persson C GA. Some pharmacological aspects on xanthines in asthma. Eur J Resp Dis 1980; 61(Suppl 109)7
   Google Scholar
• Vozeh S, Kewitz G, Perruchoud A, et al. Theophylline serum concentration and therapeutic effect in severe acute bronchial obstruction: The optimal use of intravenously administered aminophylline. Am Rev Resp Dis 1982; 125: 181
   PubMedGoogle Scholar
• Rossing T H, Fanta C H, Goldstein D H, Snapper J R, McFadden E R, Jr. Emergency therapy of asthma: Comparison of the acute effects of par-enteral and inhaled sympathomimetic and infused aminophylline. Am Rev Resp Dis 1980; 122: 365
   PubMed Web of Science ®Google Scholar
• Levy G, Koysooko R. Pharmacokineric analysis of the effect of theophylline on pulmonary function in asthmatic children. J Pediatr 1975; 86: 789
   PubMed Web of Science ®Google Scholar
• Maselli R, Casal G L, Ellis E F. Pharmacologic effects of intravenously administered aminophylline in asthmatic children. J Pediatr 1970; 76: 777
   PubMed Web of Science ®Google Scholar
• Rachelefsky G S, Katz R M, Siegel S C. A sustained release theophylline preparation: efficacy in childhood asthma with low serum theophylline levels. Ann Allergy 1978; 40: 252
   PubMedGoogle Scholar
• Estenne M, Yernault J-C, DeTroyer A. Effects of parenteral aminophylline on lung mechanics in normal humans. Am Rev Resp Dis 1980; 121: 967
   PubMedGoogle Scholar
• Weinberger M, Bronsky G, Bensch G W, et al. Interaction of ephedrine and theophylline. Clin Pharmac Ther 1975; 17: 585
   PubMed Web of Science ®Google Scholar
• Hambleton G, Weinberger M, Godfrey S, et al. Comparison of cromoglycate and theophylline in controlling symptoms of chronic asthma. Lancet 1977; 1: 381
   PubMed Web of Science ®Google Scholar
• Bierman C W, Shapiro C G, Pierson W E, et al. Acute and chronic theophylline therapy in exercise-induced bronchospasm. Pediatrics 1977; 60: 845
   PubMed Web of Science ®Google Scholar
• Pollock J, Kieckel F, Cooper D, et al. Relationship of serum theophylline concentration to inhibition of exercise-induced bronchospasm and comparison with cromolyn. Pediatrics 1977; 60: 840
   PubMed Web of Science ®Google Scholar
• James L, Faciane J, Sly R M. Effect of treadmill exercise on asthmatic children. J Allergy Clin Immunol 1976; 57: 408
   PubMed Web of Science ®Google Scholar
• Haynes R L, Ingram R H, McFadden E R. An assessment of the pulmonary response to exercise in asthma and an analysis of the factors influencing it. Am Rev Resp Dis 1976; 114: 739
   PubMed Web of Science ®Google Scholar
• Chryssanthopoulus C, Bruns W T, Maksud M G, et al. Quantitative effect of theophylline anhydrous on exercise-induced asthma after maximal physical effort. Ann Ellergy 1979; 422: 355
   Google Scholar
• Godfrey S, Konig P. Inhibition of exercise-induced asthma by different pharmacologic pathways. Thorax 1976; 31: 137
   PubMed Web of Science ®Google Scholar
• Anderson S D, Seale J P, Rosea P, et al. Inhaled and oral salbutamol in exercise-induced asthma. Am Rev Resp Dis 1976; 114: 493
   PubMed Web of Science ®Google Scholar
• Eggleston P A, Beasly P P. Bronchodilation and inhibition of induced asthma by adrenergic agonists. Clin Pharmacol Ther 1981; 29: 505
   PubMed Web of Science ®Google Scholar
• Sheppard D, Epstein J, Holtzman M J, et al. Dose-dependent inhibition of cold air-induced bron-choconstriction by atropine. J Appl Physiol: Resp Environ Exercise Physiol 1982; 53: 169
   PubMed Web of Science ®Google Scholar
• McWilliams B, Menendez R, Kelly H W, Howick J. Effects of theophylline on inhaled methacholine and histamine in asthmatic children. Am Rev Resp Dis 1982; 125(2)191
   Google Scholar
• Ogilvie R I. Clinical pharmacokinetics of theophylline. Clin Pharmacokinet 1978; 3: 267
   PubMed Web of Science ®Google Scholar
• Jonkman J H, Tang D, Upton R A, Riegelman S. Measurement of excretion characteristics of theophylline and its major metabolites. Eur J Clin Pharmacol 1981; 20: 435
   PubMed Web of Science ®Google Scholar
• Jusko W J, Eaton M L. Factors affecting theophylline disposition. Theophylline Therapy Update, S M Macleod, A Isles. Astra Pharmaceuticals, Mississauga, Ontario 1982; 19
   Google Scholar
• Tang-Liu D, Williams R L, Riegelman S. Nonlinear theophylline elimination. Clin Pharmacol Ther 1982; 31: 358
   PubMed Web of Science ®Google Scholar
• Weinberger M, Ginchansky E. Dose-dependent kinetics of theophylline disposition in asthmatic children. J Pediatr 1977; 91: 820
   PubMed Web of Science ®Google Scholar
• Upton R A, Thiercelin J-R, Guentert T W, et al. Intraindividual variability in theophylline pharmacokinetics: Statistical verification in 39 of 60 healthy young adults. J Pharmacokinet Biophar-maceut 1982; 10: 123
   PubMedGoogle Scholar
• Leung P, Kalisker A, Bell T D. Variation in theophylline clearance rate with time in chronic childhood asthma. J Allergy Clin Immunol 1977; 59: 440–444
   PubMed Web of Science ®Google Scholar
• Jenne J W, Wyze G, Rood F S, et al. Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline. Clin Pharmacol Ther 1972; 13: 349
   PubMed Web of Science ®Google Scholar
• Svedmyr N. Long term theophylline therapy. Eur J Respir Dis 1980; 61(Suppl 109)5
   Google Scholar
• Bell T, Bigley J. Sustained-release theophylline therapy for chronic childhood asthma. Pediatrics 1978; 62: 352
   PubMed Web of Science ®Google Scholar
• Tinkelman D G, Vanderpool G E, Carroll M S, et al. Compliance differences following administration of theophylline at six and twelve-hour intervals. J Allergy Clin Immunol 1980; 44: 283
   Google Scholar
• Weinberger M, Hendeles L, Bighley J. The relationship of product formulation to absorption of oral theophylline. N Engl J Med 1978; 299: 852
   PubMed Web of Science ®Google Scholar
• Weinberger M, Hendeles L, Wong L, et al. Relationship of formulation and dosing interval to fluctuation of serum theophylline concentration in children with chronic asthma. J Pediatr 1981; 99: 145
   PubMed Web of Science ®Google Scholar
• Spangler D L, Kalof D D, Bloom F L, et al. Theophylline bioavailiability following oral administration of six sustained-release preparations. Ann Allergy 1978; 40: 6
   PubMedGoogle Scholar
• Kelly H W, Murphy S. Serum theophylline levels in asthmatic children receiving sustained-release theophylline tablets. Am J Hosp Pharmacol 1979; 36: 1698
   PubMedGoogle Scholar
• Kelly H W, Murphy S. Efficacy of a 12-hour sustained release preparation in maintaining therapeutic serum theophylline levels in asthmatic children. Pediatrics 1980; 66: 97
   PubMed Web of Science ®Google Scholar
• Tabachnik E, Scott P, Macleod S, et al. Sustained-release theophylline in the treatment of childhood asthma—A significant advance. J Pediatr 1982; 100: 489
   PubMed Web of Science ®Google Scholar
• Trembath P W, Boobis S W. Plasma theophylline levels after sustained-release aminophylline. Clin Pharmacol Ther 1979; 26: 654
   PubMed Web of Science ®Google Scholar
• Talseth T, Boye N P, Bredesen J E, et al. A comparison of the plasma profiles of two slow-release theophylline (Nuelin Depot and Theodur) in healthy volunteers. Ann Allergy 1981; 46: 279
   PubMedGoogle Scholar
• Goldberg P, Leffert F, Gonzalez M, et al. Intravenous aminophylline therapy for asthma: A comparison of two methods of administration in children. Am J Dis Child 1980; 134: 596
   PubMedGoogle Scholar
• Phillips M J, Oilier S, Trembath P W, et al. The effect of sustained-release aminophylline on exercise-induced asthma. Br J Dis Chest 1981; 75: 181
   PubMedGoogle Scholar
• Simons F ER, Luciuk G H, Simons K J. Sustained-release theophylline for the treatment of asthma in children. Theophylline Therapy Update, S M Macleod, A Isles. Astra Pharmaceuticals, Mississauga, Ontario 1982; 63–68
   Google Scholar
• Simons F ER, Luciuk G H, Simons K J. Sustained-release theophylline for treatment of asthma in preschool children. Am J Dis Child 1982; 136: 790
   PubMedGoogle Scholar
• Menendez R, Kelly H W, Howick J, et al. Phar-macokinetic and therapeutic comparison of two sustained-release theophylline preparations. Am J Dis Child, (in press)
   Google Scholar